Post-induction lymph node delineation in nasopharyngeal cancer: A single-center experience

Head Neck. 2023 Mar;45(3):612-619. doi: 10.1002/hed.27274. Epub 2022 Dec 12.

Abstract

Background: We routinely delineate the gross tumor volume (GTV) for the lymph nodes (LN) based on post-induction chemotherapy (IC) MRI in nasopharyngeal carcinoma (NPC). Herein, we investigated the sufficiency of this method, particularly in high-risk LNs.

Methods: Eighty-one LNs with a high-risk of clinical extranodal extension and/or ≥3-cm diameter in 58 patients were evaluated. A new GTV covering the pre-IC LN volume was delineated for each LN.

Results: The median volume reduction was 72.5% for the GTV and 53.1% for the planning target volume. After a median 43 months, the overall LN local control rate was 97.5%. The 2- and 5-year LN recurrence-free survival, overall survival, and disease-free survival rate was 88.3% and 84.4%, 92.5% and 85.1%, and 86.8% and 79.2%, respectively.

Conclusion: IC yields a significant reduction in nodal target volumes, and post-IC nodal volume-based radiotherapy provides excellent LC in NPC, even in high-risk LNs.

Keywords: induction chemotherapy; lymph node volume; nasopharyngeal cancer; radiotherapy; target volume delineation.

MeSH terms

  • Disease-Free Survival
  • Humans
  • Induction Chemotherapy
  • Lymph Nodes / diagnostic imaging
  • Lymph Nodes / pathology
  • Nasopharyngeal Carcinoma / pathology
  • Nasopharyngeal Neoplasms* / drug therapy
  • Nasopharyngeal Neoplasms* / therapy